Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay
- Resource Type
- Article
- Source
- In
Clinical Biochemistry February 2022 100:35-41 - Subject
- Language
- ISSN
- 0009-9120